ABVC BIOPHARMA, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ABVC BioPharma, Inc. on July 2, 2026. The report discloses a change in the company's independent registered public accounting firm effective June 30, 2026.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the change in auditors and related disclosures.
Material Changes
- Accountant Change: The Audit Committee dismissed Simon & Edward, LLP ("S&E") and engaged Kreit & Chiu CPA LLP ("KC") as the new independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Previous Auditor Tenure: S&E served as the auditor from October 17, 2024, to June 30, 2026.
- Audit Opinions: S&E's reports for fiscal years 2024 and 2025 did not contain adverse opinions or disclaimers. However, they included an explanatory paragraph regarding the Company's ability to continue as a going concern.
- Disagreements: There were no disagreements with S&E on accounting principles, practices, or auditing scope during the two most recent fiscal years.
- Reportable Events: No reportable events occurred except for previously disclosed material weaknesses in internal control over financial reporting.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or new risk factors. The primary risk highlighted is the previously disclosed material weaknesses in internal controls and the going concern qualification noted in prior audit reports.
Investor Verification Checklist
- Verify the status of the "going concern" qualification mentioned in the 2024 and 2025 audit reports.
- Review the details of the previously disclosed material weaknesses in internal control over financial reporting.
- Confirm the engagement letter and scope of work with the new auditor, Kreit & Chiu CPA LLP.
- Examine the letter from the former auditor (S&E) filed as Exhibit 16.1 for any additional context.